Titlebook: Measles and Poliomyelitis; Vaccines, Immunizati Edouard Kurstak (President - International Compara Book 1993 Springer-Verlag/Wien 1993 Anti

泰然自若

palliate

T. F. Wildhe same time, the increasing number of treaties should also be causing concern. The more treaties that are concluded, the more treaties that will have to be applied; and the more treaties that are applied, the 978-90-481-7614-4978-1-4020-6362-6Series ISSN 1572-4395 Series E-ISSN 2215-0315

盡責(zé)

GLARE

不可救藥

Measles vaccine — one versus two doses: why and whengy. It may be better to identify and vaccinate high-risk groups and thus ensure high first-dose coverage at an appropriate age, rather than to give 90% of the population two doses and 10% of the population no doses.

inculpate

Psa617

exophthalmos

Recent approaches in the development of measles vaccinesity related to the structure of the peptides -length, construction, way of presentation -and their recognition by the largest possible number of individuals. The developfrnent of adjuvants is complementary to synthetic vaccines. Different adjuvants are developed in order to enhance the immunogenicit

虛度